Orphazyme A/S (ORPH) Short Interest Ratio & Short Volume → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free ORPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Orphazyme A/S Short Interest DataCurrent Short Volume841,500 sharesPrevious Short Volume358,600 sharesChange Vs. Previous Month+134.66%Dollar Volume Sold Short$475,447.50Short Interest Ratio / Days to Cover0.6Last Record DateMarch 15, 2022Outstanding Shares35,312,000 sharesPercentage of Shares Shorted2.38%Today's Trading Volume941,400 sharesAverage Trading Volume1,371,185 sharesToday's Volume Vs. Average69% Short Selling Orphazyme A/S ? Sign up to receive the latest short interest report for Orphazyme A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatORPH Short Interest Over TimeORPH Days to Cover Over TimeORPH Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Orphazyme A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2022841,500 shares $475,447.50 +134.7%N/A0.6 $0.57 2/28/2022358,600 shares $437,492.00 -67.4%N/A0.4 $1.22 2/15/20221,100,000 shares $2.34 million +283.3%N/A1.1 $2.13 1/31/2022287,000 shares $568,260.00 -7.9%N/A0.5 $1.98 1/15/2022311,700 shares $716,910.00 -5.4%N/A0.4 $2.30 12/31/2021329,600 shares $794,336.00 +214.5%N/A0.2 $2.41 Get the Latest News and Ratings for ORPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orphazyme A/S and its competitors with MarketBeat's FREE daily newsletter. 12/15/2021104,800 shares $287,152.00 -73.0%N/A0.1 $2.74 11/30/2021388,300 shares $1.26 million -37.3%N/A0.3 $3.24 11/15/2021619,100 shares $2.47 million +25.8%N/A0.4 $3.99 10/29/2021492,100 shares $1.91 million -59.3%N/A0.1 $3.89 10/15/20211,210,000 shares $5.14 million +300.0%N/A0.3 $4.25 9/30/2021302,500 shares $1.24 million +0.6%N/A0.1 $4.11 9/15/2021300,600 shares $1.41 million -35.7%N/A0.1 $4.69 8/31/2021467,300 shares $2.43 million -71.7%N/A0 $5.21 8/13/20211,650,000 shares $8.50 million +280.6%N/A0.1 $5.15 7/30/2021433,500 shares $2.07 million -15.7%N/A0 $4.78 7/15/2021514,000 shares $2.67 million -41.1%N/A0 $5.19 6/30/2021873,200 shares $6.42 million +19.3%N/A0.1 $7.35 6/15/2021731,800 shares $7.35 million +1,973.1%N/A0.1 $10.05 5/28/202135,300 shares $197,680.00 +141.8%N/A0.2 $5.60 5/14/202114,600 shares $79,570.00 +28.1%N/A0.3 $5.45 4/30/202111,400 shares $107,844.00 -48.9%N/A0.2 $9.46 4/15/202122,300 shares $216,310.00 -69.1%N/A0.4 $9.70 3/31/202172,100 shares $669,088.00 +305.1%N/A1.4 $9.28 3/15/202117,800 shares $232,290.00 +53.5%N/A2.2 $13.05 2/26/202111,600 shares $143,956.00 +56.8%N/A1.1 $12.41 2/12/20217,400 shares $91,686.00 +270.0%N/A0.7 $12.39 1/29/20212,000 shares $23,500.00 -54.6%N/A0.2 $11.75 1/15/20214,400 shares $56,848.00 No ChangeN/A0.2 $12.92 ORPH Short Interest - Frequently Asked Questions What is Orphazyme A/S's current short interest? Short interest is the volume of Orphazyme A/S shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 841,500 shares of ORPH short. Learn More on Orphazyme A/S's current short interest. What is a good short interest ratio for Orphazyme A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORPH shares currently have a short interest ratio of 1.0. Learn More on Orphazyme A/S's short interest ratio. Is Orphazyme A/S's short interest increasing or decreasing? Orphazyme A/S saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 841,500 shares, an increase of 134.7% from the previous total of 358,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Orphazyme A/S's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Orphazyme A/S: Aprea Therapeutics, Inc. (2.35%), Theratechnologies Inc. (0.06%), CASI Pharmaceuticals, Inc. (1.31%), Lexaria Bioscience Corp. (4.25%), Spruce Biosciences, Inc. (1.46%), JanOne Inc. (2.92%), Viracta Therapeutics, Inc. (2.37%), Fortress Biotech, Inc. (14.08%), ImmunoPrecise Antibodies Ltd. (1.48%), VYNE Therapeutics Inc. (0.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($6.96 billion), Charter Communications, Inc. ($5.13 billion), Palo Alto Networks, Inc. ($4.41 billion), Occidental Petroleum Co. ($2.91 billion), Lucid Group, Inc. ($2.40 billion), Wayfair Inc. ($2.01 billion), Live Nation Entertainment, Inc. ($1.85 billion), HP Inc. ($1.84 billion), Avis Budget Group, Inc. ($1.68 billion), and Rivian Automotive, Inc. ($1.66 billion). View all of the most shorted stocks. What does it mean to sell short Orphazyme A/S stock? Short selling ORPH is an investing strategy that aims to generate trading profit from Orphazyme A/S as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Orphazyme A/S? A short squeeze for Orphazyme A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORPH, which in turn drives the price of the stock up even further. How often is Orphazyme A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORPH, twice per month. The most recent reporting period available is March, 15 2022. More Short Interest Resources from MarketBeat Related Companies: Aprea Therapeutics Short Squeeze Theratechnologies Short Squeeze CASI Pharmaceuticals Short Squeeze Lexaria Bioscience Short Squeeze Spruce Biosciences Short Squeeze JanOne Short Squeeze Viracta Therapeutics Short Squeeze Fortress Biotech Short Squeeze ImmunoPrecise Antibodies Short Squeeze VYNE Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORPH) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends